🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Amazing didactic demonstration of USG puncture for ECIRS by Thomas Chi and our host Thomas Tailly !!! Get on line and join us at BEAM 25 meeting!!! #BEAM25

ⵁ Proud to share the publication of STUMPS ➡️ Suction Technology Utility in Mini PCNL Study📌 30 centers, 21 countries, 1707 patients, 56% supine, 0.2% sepsis, 82% stone-free🪨 A global effort now live (May 1st, 2025) Thanks DrG for invite us🇲🇽 #MiniPCNL #STUMPS

Leonardo Gomes showing live an # ERBT. Great technique, future (present) of treatment of superficial bladder tumors. #NovoOrizonti2.0 Marcelo Wroclawski Jeremy Teoh

This was a new one… On-line presentation directly from the Amazon Forest! Thanks for the invitation Leonardo Gomes #UroSoMe #ERBT

Enjoy #STUMPS first paper!

The future of suction in ureteroscopy - inspiring lecture by Olivier Traxer at #UROBESTT25. Lab and initial clinical tests look impressive. More exciting info to be revealed at #ICE25. European Association of Urology (EAU) European School of Urology (EAU ESU) PETRA PEARLS

LASER enucleation is also a good indication for prostate cancer patients! ☑️large prostate before radiotherapy ☑️advanced cancer under retention or very symptomatic ☑️low risk patients with large prostate under WW or AS

Unprecedented response 🙏🙏 ❤️grateful 2 all Let's make this an evidence based success Steffi Yuen Thomas RW Herrmann Prof Bhaskar Somani Daniele Castellani #UroSoMe European Association of Urology (EAU) PEARLS @ClearPetra-Well Lead Innovex Medical Shenzhen HugeMed MacroLux Medical Pusen Medical Quanta Surgery AUSET

This is one of my all-time favorite BPH videos youtu.be/JT4IAihRHyE?si… by the genius urologist Bertrand Lukacs. Watching the ‘rolling ball’ median lobe was an epiphany for me…

More unused phone lines! GSA saved ~$800k/year by eliminating ~1,700 unused plans, switching plans for many of the remaining ones, and eliminating 2,218 unused cellular equipment payments. SBA reduced its VOIP licenses from 9,195 to 2,690, eliminating 6,505

Your study is a great contribution to understand the role of the new technologies in stone surgery outcomes. How are we choosing the best DUST and SUCTION combination for each patient? #PatientStoneApproach

robot-assisted radical prostatectomy with four different platforms: Da Vinci Xi, Hugo RAS, Versius, Toumai. Same surgeon, same steps. Here’s the side-by-side comparison video: 👉 drive.google.com/file/d/1mMpG3v…

🤚🏻I would sugest to include DUSTING to make a pentafecta for stone treatment! 🗣️Different energies may lead to different outcomes in stone fragmentation and also influence the results of other factors: suction, temperarure and pressure!

A big challenge in NMIBC is proper patient follow up specially in private practice in Brasil. ✅Public health institutions with residency programs or vinculated to univesrsities may have more capacity of following gudelines and protocols ⚠️Limitations (IMO) in private practeice

Risk stratification for active surveillance in low and intermediate-risk #BladderCancer. Marco Moschini Ospedale San Raffaele and Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center discuss expanding active surveillance criteria for recurrent low-grade bladder cancer. #WatchNow > bit.ly/42wshVz

#ERBT is the way to go! The energy source should NOT be an obstacle for you to start!! It can be done with monopolar, bipolar or laser. Great example of how to do it with bipolar energy Mohamed_omar

SingleUse/Reusable,best 4 #FANS World Journal of Urology European Association of Urology (EAU) Amelia Pietropaolo Dr. Ben Chew Naeembhojani7 Jia-Lun Kwok Anil Shrestha Wenster Khi Yung Guohua Zeng Thomas RW Herrmann Yi Quan Tan Innovex Medical Pusen Medical MacroLux Medical REDPINE Pablo Contreras #FanofFANS #UroSoMe

🚨 NEW in #EuropeanUrology By Saum Ghodoussipour Roger Li Sarah P. Psutka MD MS Trinity J. Bivalacqua Joan Palou Redorta et al Can novel intravesical therapies change the game for non–muscle-invasive bladder cancer? This systematic review explores: ✅ BCG-based combos ✅ Gene & immune therapies ✅ Innovative drug

Not all rising PSAs are equal. A population study of 17,753 men redefines high-risk biochemical recurrence (HR-BCR) after prostate cancer treatment. Half of men with PSA rise don’t need treatment intensification. Time, doubling rate, and risk matter more than one number.

🚨What's in a name? Why differentiation between biochemical recurrence and metastatic #prostatecancer matters 👏 New review led by Anael Rizzo David Geffen School of Medicine at UCLA & Pratik Kanabur UCLA Urology 👉Differentiating BCR & metastatic risk groups is 🔑 to help personalize care for our patients